Stay updated with breaking news from Nasdaq Bfri. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biofrontera Inc. (NASDAQ:BFRI – Get Free Report) saw a significant increase in short interest in April. As of April 15th, there was short interest totalling 44,000 shares, an increase of 26.4% from the March 31st total of 34,800 shares. Based on an average trading volume of 759,100 shares, the short-interest ratio is currently 0.1 days. […]
Biofrontera (NASDAQ:BFRI – Get Free Report) and Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, valuation, analyst recommendations and institutional ownership. Profitability This table compares Biofrontera and Syndax Pharmaceuticals’ […]
Biofrontera (NASDAQ:BFRI – Get Free Report) and Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, institutional ownership, analyst recommendations and profitability. Valuation & Earnings This table compares Biofrontera and […]
Biofrontera Inc. (NASDAQ:BFRI – Get Free Report) shares dropped 5.6% during trading on Tuesday . The stock traded as low as $0.84 and last traded at $0.89. Approximately 374,170 shares were traded during mid-day trading, a decline of 24% from the average daily volume of 493,719 shares. The stock had previously closed at $0.94. Biofrontera […]
Biofrontera (NASDAQ:BFRI – Get Free Report) is scheduled to be posting its quarterly earnings results after the market closes on Thursday, November 9th. Analysts expect Biofrontera to post earnings of ($5.18) per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link. Biofrontera (NASDAQ:BFRI – Get […]